PL367084A1 - Sulfonoamidy 2-(podstawionego-amino) benzoksazolujako inhibitory proteazy HIV o szerokim zakresie działania - Google Patents

Sulfonoamidy 2-(podstawionego-amino) benzoksazolujako inhibitory proteazy HIV o szerokim zakresie działania

Info

Publication number
PL367084A1
PL367084A1 PL02367084A PL36708402A PL367084A1 PL 367084 A1 PL367084 A1 PL 367084A1 PL 02367084 A PL02367084 A PL 02367084A PL 36708402 A PL36708402 A PL 36708402A PL 367084 A1 PL367084 A1 PL 367084A1
Authority
PL
Poland
Prior art keywords
broadspectrum
amino
substituted
protease inhibitors
hiv protease
Prior art date
Application number
PL02367084A
Other languages
English (en)
Inventor
Dominique Louis Nestor Ghislain Surleraux
Sandrine Marie Helene Vendeville
Wim Gaston Verschueren
Bethune Marie-Pierre T.M.M.G. De
Kock Herman Augustinus De
Abdellah Tahri
Sola Montserrat Erra
Original Assignee
Tibotec Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharmaceuticals Ltd. filed Critical Tibotec Pharmaceuticals Ltd.
Publication of PL367084A1 publication Critical patent/PL367084A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL02367084A 2001-04-09 2002-04-09 Sulfonoamidy 2-(podstawionego-amino) benzoksazolujako inhibitory proteazy HIV o szerokim zakresie działania PL367084A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201308 2001-04-09
US28770401P 2001-05-02 2001-05-02

Publications (1)

Publication Number Publication Date
PL367084A1 true PL367084A1 (pl) 2005-02-21

Family

ID=26076876

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367084A PL367084A1 (pl) 2001-04-09 2002-04-09 Sulfonoamidy 2-(podstawionego-amino) benzoksazolujako inhibitory proteazy HIV o szerokim zakresie działania

Country Status (25)

Country Link
US (2) US7244752B2 (pl)
EP (1) EP1397367A2 (pl)
JP (1) JP4417010B2 (pl)
KR (1) KR100872029B1 (pl)
CN (1) CN100491360C (pl)
AP (1) AP1544A (pl)
AR (1) AR035819A1 (pl)
AU (1) AU2002257774B2 (pl)
BG (1) BG66371B1 (pl)
BR (1) BR0208796A (pl)
CA (1) CA2442870C (pl)
CZ (1) CZ303139B6 (pl)
EA (1) EA007383B1 (pl)
EE (1) EE05384B1 (pl)
HR (1) HRP20030905B1 (pl)
HU (1) HUP0303744A3 (pl)
IL (1) IL158092A0 (pl)
MX (1) MXPA03009179A (pl)
NO (1) NO328896B1 (pl)
NZ (1) NZ528954A (pl)
OA (1) OA12464A (pl)
PL (1) PL367084A1 (pl)
SK (1) SK288232B6 (pl)
WO (1) WO2002081478A2 (pl)
ZA (1) ZA200307683B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4417010B2 (ja) * 2001-04-09 2010-02-17 テイボテク・フアーマシユーチカルズ・リミテツド 広範囲2−(置換−アミノ)−ベンズオキサゾールスルホンアミドhivプロテアーゼ阻害剤
ATE429431T1 (de) * 2001-05-11 2009-05-15 Tibotec Pharm Ltd 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
AU2003202914A1 (en) * 2002-01-07 2003-07-24 Sequoia Pharmaceuticals Broad spectrum inhibitors
US7285566B2 (en) * 2002-01-07 2007-10-23 Erickson John W Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
HRP20050607B1 (hr) * 2002-05-17 2014-07-04 Tibotec Pharmaceuticals Ltd. Supstituirani benzizoksazol sulfonamid hiv proteazni inhibitori širokog spektra
US7807845B2 (en) * 2004-03-11 2010-10-05 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
WO2005110428A2 (en) * 2004-05-07 2005-11-24 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
CN101128469B (zh) 2005-02-25 2012-11-14 泰博特克药品有限公司 蛋白酶抑制剂前体的合成
DE102010044584A1 (de) * 2010-09-07 2012-03-08 Kautex Textron Gmbh & Co. Kg Kraftstoffbehälter aus thermoplastischem Kunststoff
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021326A1 (de) 1980-06-06 1981-12-17 Drägerwerk AG, 2400 Lübeck Einrichtung zur messung von mindestens zwei pneumatischen lungenparametern und messverfahren hierzu
US4448192A (en) 1982-03-05 1984-05-15 Hewlett Packard Company Medical ventilator device parametrically controlled for patient ventilation
IT1185906B (it) 1985-09-13 1987-11-18 Luciano Gattinoni Sistema ed apparecchio biomedicale per la misurazione con precisione dei valori di variazione di pressione e volume nei polmoni di un paziente
DE3919840A1 (de) 1989-06-17 1991-01-17 Hoechst Ag Verfahren zur herstellung von aromatischen sulfonsaeurechloriden
US5136043A (en) 1989-06-17 1992-08-04 Hoechst Aktiengesellschaft Process for the preparation of aromatic sulfonyl chlorides
ATE141635T1 (de) 1990-03-09 1996-09-15 Milliken Res Corp Organische materialien, die sulfonamidogebundene poly(oxyalkylen)gruppen tragen und ihre herstellung
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
AU7669794A (en) * 1993-08-24 1995-03-21 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
CZ289214B6 (cs) 1993-10-01 2001-12-12 Astra Aktiebolag Způsob zpracování jemně děleného práąkového léčiva, zařízení k provádění tohoto způsobu a aglomeráty vyrobené tímto způsobem
ATE191907T1 (de) 1993-11-23 2000-05-15 Searle & Co Verfahren zur herstellung von zwischenprodukten, die für die herstellung von retroviral-protease hemmenden verbindungen verwendbar sind
EP1586558A3 (en) * 1995-01-20 2005-10-26 G.D. Searle LLC. Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
RU2174519C2 (ru) * 1995-03-10 2001-10-10 Джи. Ди. Сирл Энд Ко. Гидроксиэтиламино сульфонамиды гетероциклокарбонил аминокислоты, ингибирующие ретровирусную протеазу
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
JP2000515488A (ja) * 1995-11-15 2000-11-21 ジー.ディー.サール アンド カンパニー 置換スルホニルアルカノイルアミノヒドロキシエチルアミノスルホンアミド レトロウイルスプロテアーゼ阻害剤
GB9525994D0 (en) 1995-12-20 1996-02-21 Univ Manitoba Improvements in delivery of assist modes of mechanical ventilation
ATE255883T1 (de) 1996-05-20 2003-12-15 Janssen Pharmaceutica Nv Fungizide mittel mit verbesserter bioverfügbarkeit
AU734248B2 (en) 1997-03-26 2001-06-07 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
SE513969C2 (sv) 1997-05-17 2000-12-04 Draegerwerk Ag Anordning och förfarande för bestämning av respirationssystemetsmekaniska egenskaper
WO1999006254A1 (de) * 1997-07-31 1999-02-11 Continental Teves Ag & Co. Ohg Verfahren und vorrichtung zur aktivierung einer bremsanlage
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
ID25551A (id) 1997-12-24 2000-10-12 Vertex Pharma Bahan baku obat penghambat protease aspartil
PT1088098E (pt) 1998-06-23 2011-05-25 Univ Illinois Medicamento para tratar mam?feros infectados com hiv
AU4828199A (en) * 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
OA12053A (en) * 1999-10-06 2006-05-02 Tibotec Pharm Ltd HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor.
JP4417010B2 (ja) * 2001-04-09 2010-02-17 テイボテク・フアーマシユーチカルズ・リミテツド 広範囲2−(置換−アミノ)−ベンズオキサゾールスルホンアミドhivプロテアーゼ阻害剤

Also Published As

Publication number Publication date
NZ528954A (en) 2005-04-29
EP1397367A2 (en) 2004-03-17
US7244752B2 (en) 2007-07-17
BG108218A (bg) 2004-09-30
US20070135447A1 (en) 2007-06-14
HRP20030905B1 (en) 2012-03-31
CA2442870A1 (en) 2002-10-17
NO20034505L (no) 2003-12-08
US7595334B2 (en) 2009-09-29
KR20030090719A (ko) 2003-11-28
CZ303139B6 (cs) 2012-04-25
BG66371B1 (bg) 2013-10-31
WO2002081478A2 (en) 2002-10-17
HUP0303744A2 (hu) 2004-03-01
EE05384B1 (et) 2011-02-15
EA007383B1 (ru) 2006-10-27
AP2003002882A0 (en) 2003-12-31
HUP0303744A3 (en) 2008-03-28
CN100491360C (zh) 2009-05-27
MXPA03009179A (es) 2004-11-22
CZ20032936A3 (cs) 2004-05-12
AU2002257774B2 (en) 2007-08-30
AP1544A (en) 2006-01-12
BR0208796A (pt) 2004-03-09
ZA200307683B (en) 2005-03-30
JP2004529144A (ja) 2004-09-24
OA12464A (en) 2006-05-24
EA200301110A1 (ru) 2004-04-29
CN1636006A (zh) 2005-07-06
HRP20030905A2 (en) 2005-08-31
IL158092A0 (en) 2004-03-28
AR035819A1 (es) 2004-07-14
CA2442870C (en) 2011-08-02
SK13392003A3 (en) 2004-10-05
NO20034505D0 (no) 2003-10-08
EE200300494A (et) 2003-12-15
WO2002081478A3 (en) 2003-05-01
NO328896B1 (no) 2010-06-07
KR100872029B1 (ko) 2008-12-05
SK288232B6 (sk) 2014-11-04
US20040132791A1 (en) 2004-07-08
JP4417010B2 (ja) 2010-02-17

Similar Documents

Publication Publication Date Title
IL157171A0 (en) Broadspectrum 2-(substituted-amino) -benzothiazole sulfonamide hiv protease inhibitors
IS7305A (is) HIV-integrasa tálmar
IL158093A0 (en) Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
IL158092A0 (en) Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
AP1878A (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors.
ZA200410156B (en) Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
IL162574A0 (en) Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
PL375307A1 (pl) Podstawione oksoindolo sulfonamidy jako inhibitory proteazy HIV o szerokim zakresie działania
HRP20040936A2 (en) Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
TWI340135B (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
HK1063800A (en) Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
ZA200500926B (en) Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
ATA13902001A (de) Werkzeugmaschine
AU2002255485A8 (en) Hiv/fiv protease inhibitors
HK1079684A (en) Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
EE00272U1 (et) Sõrmus-hoidja